[The value of antitachycardia pacemaker therapy in patients with Wolff-Parkinson-White syndrome].
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002036:Bundle of His / Q000187:drug effects / Q000601:surgery; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004206:Disopyramide / Q000627:therapeutic use; D004562:Electrocardiography; D006801:Humans; D008801:Mexiletine / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D011405:Propafenone; D011427:Propiophenones / Q000627:therapeutic use; D013610:Tachycardia / Q000628:therapy; D014700:Verapamil / Q000627:therapeutic use; D014927:Wolff-Parkinson-White Syndrome / Q000628:therapy*
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D011427:Propiophenones; D008801:Mexiletine; D011405:Propafenone; D014700:Verapamil; D004206:Disopyramide
Stellenwert der antitachykarden Schrittmachertherapie bei Patienten mit WPW-Syndrom.